Up to one-third of patients referred for transcatheter tricuspid valve intervention (TTVI) have a transvalvular pacemaker (PPM) or implantable cardioverter-defibrillator (ICD) lead in place. Both the electrophysiology and interventional cardiology communities have been alerted to the complexity of decision-making in this situation due to potential interactions between the leads and the TTVI material, including the risk of jailing or damage to the leads. This document, commissioned by the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions of the ESC, reviews the scientific evidence to inform Heart Team discussions on the management of patients with a PPM or ICD who are scheduled for or have undergone TTVI. Graphical abstract.

Aix Marseille Université C2VN 13005 Marseille France Bd Jean Moulin 13005 Marseille France

Assistance Publique Hôpitaux de Marseille Centre Hospitalier Universitaire La Timone Service de Cardiologie 264 Rue Saint Pierre 13005 Marseille France

Bern University Hospital University of Bern Bern Switzerland

Cardiac Pacing Unit Cardiology Departement University Hospital of Geneva Geneva Switzerland

Cardio Center IRCCS Humanitas Research Hospital Rozzano Milan Italy

Cardiology Department Université de Grenoble Alpes INSERM CHU Grenoble Alpes LRB 38000 Grenoble France

Department of Cardiology Aarhus University Hospital Aarhus Denmark

Department of Cardiology Centre Cardiologique du Nord Saint Denis France

Department of Cardiology Liverpool Heart and Chest Hospital NHS Foundation Trust Liverpool UK

Department of Cardiology Montreal Heart Institute Université de Montréal Montreal Canada

Department of Cardiology University of Auckland and Auckland City Hospital Auckland New Zealand

Department of Cardiology University of Rennes CHU Rennes lTSI UMR1099 Rennes F 35000 France

Department of Cardiothoracic and Vascular Surgery German Heart Center of Charité Berlin Germany

Department of Clinical Medicine Aarhus University Aarhus Denmark

Division of Pediatric Cardiology Children's Hospital of Philadelphia Philadelphia PA USA

Heart Rhythm Clinic San Rossore Hospital Pisa Italy

Jesselson Integrated Heart Center Shaare Zedek Medical Center and Hebrew University Faculty of Medicine Jerusalem Israel

Zobrazit více v PubMed

https://eatlas.escardio.org/Atlas/ESC-Atlas-of-Cardiology.

Defaye P, Biffi M, El-Chami M, Boveda S, Glikson M, Piccini J et al. Cardiac pacing and lead devices management: 25 years of research at EP Europace journal. Europace. 2023;25:euad202. PubMed PMC

Tribouilloy C, Bohbot Y, Kubala M, Ruschitzka F, Popescu B, Wendler O et al. Characteristics, management, and outcomes of patients with multiple native valvular heart disease: a substudy of the EURObservational Research Programme Valvular Heart Disease II Survey. Eur Heart J. 2022;43:2756–66. PubMed

d’Arcy JL, Coffey S, Loudon MA, Kennedy A, Pearson-Stuttard J, Birks J et al. Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study. Eur Heart J. 2016;37:3515–22. PubMed PMC

Offen S, Strange G, Playford D, Celermajer DS, Stewart S. Prevalence and prognostic impact of tricuspid regurgitation in patients with cardiac implantable electronic devices: from the national echocardiography database of Australia. Intern J Cardiol. 2023;370:338–44. PubMed

Andreas M, Burri H, Praz F, Soliman O, Badano L, Barreiro M. Tricuspid valve disease and cardiac implantable electronic devices. Eur Heart J. 2024;45:346–65. PubMed PMC

Van De Heyning CM, Elbarasi E, Masiero S, Brambatti M, Ghazal S, Al-Maashani S et al. Prospective study of tricuspid regurgitation associated with permanent leads after cardiac rhythm device implantation. Can J Cardiol. 2019;35:389–95. PubMed

Paniagua D, Aldrich HR, Lieberman EH, Lamas GA, Agatston AS. Increased prevalence of significant tricuspid regurgitation in patients with transvenous pacemakers leads. Am J Cardiol. 1998;82:1130–2. PubMed

Barclay JL, Cross SJ, Leslie SJ. Entanglement of passive fix ventricular lead in tricuspid valve. Pacing Clin Electrophysiol. 2008;31:138. PubMed

Novak M, Dvorak P, Kamaryt P, Slana B, Lipoldova J. Autopsy and clinical context in deceased patients with implanted pacemakers and defibrillators: intracardiac findings near their leads and electrodes. Europace. 2009;11:1510–6. PubMed

Schilling RJ. Pacing lead entanglement in the tricuspid valve appartus during implantation. Europace. 1999;1:201. PubMed

Rothschild DP, Goldstein JA, Kerner N, Abbas AE, Patel M, Wong WS. Pacemaker-induced tricuspid regurgitation is uncommon immediately post-implantation. J Interv Card Electrophysiol. 2017;49:281–7. PubMed

Lin G, Nishimura RA, Connolly HM, Dearani JA, Sundt TM, Hayes DL. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads. J Am Coll Cardiol. 2005;45:1672–5. PubMed

Chang JD, Manning WJ, Ebrille E, Zimetbaum PJ. Tricuspid valve dysfunction following pacemaker or cardioverter-defibrillator implantation. J Am Coll Cardiol. 2017;69:2331–41. PubMed

Res JC, De Cock CC, Van Rossum AC, Schreuder J. Entrapment of tined leads. Pacing Clin Electrophysiol. 1989;12:1583–5. PubMed

Fürstenberg S, Bluhm G, Olin C. Entrapment of an atrial tined pacemaker electrode in the tricuspid valve—a case report. Pacing Clin Electrophysiol. 1984;7:760–2. PubMed

Rajappan K. Permanent pacemaker implantation technique: part II. Heart. 2009;95:334–42. PubMed

Schleifer JW, Pislaru SV, Lin G, Powell BD, Espinosa R, Koestler C. Effect of ventricular pacing lead position on tricuspid regurgitation: a randomized prospective trial. Heart Rhythm. 2018;15:1009–16. PubMed

Tatum R, Maynes EJ, Wood CT, Deb AK, Austin MA, O’Malley TJ. Tricuspid regurgitation associated with implantable electrical device insertion: a systematic review and meta-analysis. Pacing Clin Electrophysiol. 2021;44:1297–302. PubMed

Anvardeen K, Rao R, Hazra S, Hay K, Dai H, Stoyanov N. Lead-specific features predisposing to the development of tricuspid regurgitation after endocardial lead implantation. CJC Open. 2019;1:316–23. PubMed PMC

Al-Bawardy R, Krishnaswamy A, Bhargava M, Dunn J, Wazni O, Tuzcu EM. Tricuspid regurgitation in patients with pacemakers and implantable cardiac defibrillators: a comprehensive review. Clin Cardiol. 2013;36:249–54. PubMed PMC

Lee RC, Friedman SE, Kono AT, Greenberg ML, Palac RT. Tricuspid regurgitation following implantation of endocardial leads: incidence and predictors. Pacing Clin Electrophysiol. 2015;38:1267–74. PubMed

Fanari Z, Hammami S, Hammami MB, Hammami S, Shuraih M. The effects of right ventricular apical pacing with transvenous pacemaker and implantable cardioverter defibrillator on mitral and tricuspid regurgitation. J Electrocardiol. 2015;48:791–7. PubMed

Vaturi M, Kusniec J, Shapira Y, Nevzorov R, Yedidya I, Weisenberg D. Right ventricular pacing increases tricuspid regurgitation grade regardless of the mechanical interference to the valve by the electrode. Eur J Echocardiogr. 2010;11:550–3. PubMed

Zaidi SMJ, Sohail H, Satti DI, Sami A, Anwar M, Malik J. Tricuspid regurgitation in his bundle pacing: a systematic review. Ann Noninvasive Electrocardiol. 2022;27:e12986. PubMed PMC

Li X, Zhu H, Fan X, Wang Q, Wang Z, Li H et al. Tricuspid regurgitation outcomes in left bundle branch area pacing and comparison with right ventricular septal pacing. Heart Rhythm. 2022;19:1202–3. PubMed

Bednarek A, Kielbasa G, Moskal P, Ostrowska A, Bednarski A, Sondej T. Left bundle branch area pacing improves right ventricular function and synchrony. Heart Rhythm. 2024;21:2234–41. PubMed

Hai JJ, Mao Y, Zhen Z, Fang J, Wong CK, Siu CW. Close proximity of leadless pacemaker to tricuspid annulus predicts worse tricuspid regurgitation following septal implantation. Circ Arrhythm Electrophysiol. 2021;14:e009530. PubMed

Beurskens NEG, Tjong FVY, de Bruin-Bon, Dasselaar KJ, Kuijt WJ, Wilde AAM. Impact of leadless pacemaker therapy on cardiac and atrioventricular valve function through 12 months of follow-up. Circ Arrhythm Electrophysiol. 2019;12:e007124. PubMed

Salaun E, Tovmassian L, Simonnet B, Giorgi R, Franceschi F, Koutbi-Franceschi L. Right ventricular and tricuspid valve function in patients chronically implanted with leadless pacemakers. Europace. 2018;20:823–8. PubMed

Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM. 2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021;42:3427–520. PubMed

Yu YJ, Chen Y, Lau CP, Liu YX, Wu MZ, Chen YY et al. Nonapical right ventricular pacing is associated with less tricuspid valve interference and long-term progress of tricuspid regurgitation. J Am Soc Echocardiogr. 2020;33:1375–83. PubMed

De Cock CC, Vinkers M, Van Campe LC, Verhorst PM, Visser GA. Long-term outcome of patients with multiple (>=3) noninfected transvenous leads: a clinical and echocardiographic study. Pacing Clin Electrophysiol. 2000;23:423–6. PubMed

Wang TKM, Akyuz K, Mentias A, Kirincich J, Duran Crane A, Xu S et al. Contemporary etiologies, outcomes, and novel risk score for isolated tricuspid regurgitation. JACC Cardiovasc Imaging. 2022;15:731–44. PubMed

Park S-J, Gentry JL, Varma N, Wazni O, Tarakji KG, Mehta A et al. Transvenous extraction of pacemaker and defibrillator leads and the risk of tricuspid valve regurgitation. JACC Clin Electrophysiol. 2018;4:1421–8. PubMed

Dreyfus J, Audureau E, Bohbot Y, Coisne A, Lavie-Badie Y, Bouchery M. TRI-SCORE: a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery. Eur Heart J. 2022;43:654–62. PubMed PMC

Asmarats L, Perlman G, Praz F, Hensey M, Chrissoheris MP, Philippon F et al. Long-term outcomes of the FORMA transcatheter tricuspid valve repair system for the treatment of severe tricuspid regurgitation: insights from the first-in-human experience. JACC Cardiovasc Interv. 2019;12:1438–47. PubMed

Lurz J, Rommel KP, Unterhuber M, Besler C, Noack T, Borger M et al. Safety and efficacy of transcatheter edge-to-edge repair of the tricuspid valve in patients with cardiac implantable electronic device leads. JACC Cardiovasc Interv. 2019;12:2114–6. PubMed

Hahn RT, George I, Kodali SK, Nazif T, Khalique OK, Akkoc D et al. Early single-site experience with transcatheter tricuspid valve replacement. JACC Cardiovasc Imaging. 2019;12:416–29. PubMed

Lauten A, Figulla HR, Unbehaun A, Fam N, Schofer J, Doenst T. Interventional treatment of severe tricuspid regurgitation: early clinical experience in a multicenter, observational, first-in-man study. Circ Cardiovasc Interv. 2018;11:e006061. PubMed

Anderson JH, McElhinney DB, Aboulhosn J, Zhang Y, Ribichini F, Eicken A et al. Management and outcomes of transvenous pacing leads in patients undergoing transcatheter tricuspid valve replacement. JACC Cardiovasc Interv. 2020;13:2012–20. PubMed

Taramasso M, Gavazzoni M, Pozzoli A, Alessandrini H, Latib A, Attinger-Toller A. Outcomes of TTVI in patients with pacemaker or defibrillator leads: data from the TriValve registry. JACC Cardiovasc Interv. 2020;13:554–64. PubMed

Nickenig G, Weber M, Schueler R, Hausleiter J, Näbauer M, von Bardeleben. 6-Month outcomes of tricuspid valve reconstruction for patients with severe tricuspid regurgitation. J Am Coll Cardiol. 2019;73:1905–15. PubMed

Wild MG, Löw K, Rosch S, Gerçek M, Higuchi S, Massberg S et al. Multicenter experience with the transcatheter leaflet repair system for symptomatic tricuspid regurgitation. JACC Cardiovasc Interv. 2022;15:1352–63. PubMed

Webb JG, Chuang AM, Meier D, von Bardeleben RS, Kodali SK, Smith RL et al. Transcatheter tricuspid valve replacement with the EVOQUE system: 1-year outcomes of a multicenter, first-in-human experience. JACC Cardiovasc Interv. 2022;15:481–91. PubMed

Kodali S, Hahn RT, Makkar R, Makar M, Davidson CJ, Puthumana JJ. Transfemoral tricuspid valve replacement and one-year outcomes: the TRISCEND study. Eur Heart J. 2023;44:4862–73. PubMed

Wild MG, Lubos E, Cruz-Gonzalez I, Amat-Santos I, Ancona M, Andreas M et al. Early clinical experience with the TRICENTO bicaval valved stent for treatment of symptomatic severe tricuspid regurgitation: a multicenter registry. Circ Cardiovasc Interv. 2022;15:e011302. PubMed

Nickenig G, Lurz P, Sorajja P, von Bardeleben, Sitges M, Tang GHL, Hausleiter J, Trochu JN, Näbauer M, Heitkemper M, Ying SW, Weber M, Hahn RT TRILUMINATE Investigators. Percutaneous Edge-to-Edge Repair for Tricuspid Regurgitation: 3-Year Outcomes From the TRILUMINATE Study. JACC Cardiovasc Interv. 2024;17:2113–22. PubMed

Sorajja P, Whisenant B, Hamid N, Naik H, Makkar R, Tadros P, Price MJ, Singh G, Fam N, Kar S, Schwartz JG, Mehta S, Bae R, Sekaran N, Warner T, Makar M, Zorn G, Spinner EM, Trusty PM, Benza R, Jorde U, McCarthy P, Thourani V, Tang GHL, Hahn RT, Adams DH TRILUMINATE Pivotal Investigators. Transcatheter Repair for Patients with Tricuspid Regurgitation. N Engl J Med. 2023;388:1833–42. PubMed

Taramasso M, Benfari G, van der, Alessandrini H, Attinger-Toller A, Biasco L. Transcatheter versus medical treatment of patients with symptomatic severe tricuspid regurgitation. J Am Coll Cardiol. 2019;74:2998–3008. PubMed

Lurz P, Besler C, Schmitz T, Bekeredjian R, Nickenig G, Möllmann H. Short-term outcomes of tricuspid edge-to-edge repair in clinical practice. J Am Coll Cardiol. 2023;82:281–91. PubMed

Dreyfus J, Galloo X, Taramasso M, Heitzinger G, Benfari G, Kresoja KP et al. TRI-SCORE and benefit of intervention in patients with severe tricuspid regurgitation. Eur Heart J. 2023;45:586–97. PubMed

Maisano F, Hahn R, Sorajja P, Praz F, Lurz P. Transcatheter treatment of the tricuspid valve: current status and perspectives. Eur Heart J. 2024;45:876–94. PubMed

Praz F, Muraru D, Kreidel F, Lurz P, Hahn RT, Delgado V. Transcatheter treatment for tricuspid valve disease. EuroIntervention. 2021;17:791–808. PubMed PMC

Nickenig G, Weber M, Schuler R, Hausleiter J, Nabauer M, von Bardeleben. Tricuspid valve repair with the Cardioband system: two-year outcomes of the multicentre, prospective TRI-REPAIR study. EuroIntervention. 2021;16:e1264–71. PubMed PMC

Hahn RT, Makkar R, Thourani VH, Makar M, Sharma RP, Haeffele C et al. Transcatheter valve replacement in severe tricuspid regurgitation. N Engl J Med. 2025;392:115–26. PubMed

Chen M, Moschovitis A, Taramasso M. Pacemaker lead dislocation during TricValve procedure with an extremely small superior vena cava. Int J Cardiovasc Imaging. 2024;40:1149–51. PubMed PMC

Mehr M, Taramasso M, Besler C, Ruf T, Connelly KA, Weber M. 1-Year outcomes after edge-to-edge valve repair for symptomatic tricuspid regurgitation: results from the TriValve registry. JACC Cardiovasc Interv. 2019;12:1451–61. PubMed

Blasco-Turrión S, Briedis K, Estévez-Loureiro R, Sánchez-Recalde A, Cruz-González I, Pascual I. Bicaval TricValve implantation in patients with severe symptomatic tricuspid regurgitation: 1-year follow-up outcomes. JACC Cardiovasc Interv. 2024;17:60–72. PubMed

Gabriels JK, Schaller RD, Koss E, Rutkin BJ, Carrillo RG, Epstein LM. Lead management in patients undergoing percutaneous tricuspid valve replacement or repair: a ‘heart team’approach. Europace. 2023;25:euad300. PubMed PMC

Slonim SM, Semba CP, Sze DY, Dake MD. Placement of SVC stents over pacemaker wires for the treatment of SVC syndrome. J Vasc Interv Radiol. 2000;11:215–9. PubMed

Saad TF, Myers GR, Cicone J. Central vein stenosis or occlusion associated with cardiac rhythm management device leads in hemodialysis patients with ipsilateral arteriovenous access: a retrospective study of treatment using stents or stent-grafts. J Vasc Access. 2010;11:293–302. PubMed

Plant A, Stewart F, Hooks D. Implantable cardioverter-defibrillator lead failure and revision following transcutaneous bicaval valve (TricValve(R)) implantation. J Cardiovasc Electrophysiol. 2024;35:1050–4. PubMed

Olsen T, Jørgensen OD, Nielsen JC, Thogersen AM, Philbert BT, Johansen JB. Incidence of device-related infection in 97 750 patients: clinical data from the complete Danish device-cohort (1982–2018). Eur Heart J. 2019;40:1862–9. PubMed PMC

Blomström-Lundqvist C, Traykov V, Erba PA, Burri H, Nielsen JC, Bongiorni MG. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Europace. 2020;22:515–49. PubMed PMC

Wilkoff BL, Boriani G, Mittal S, Poole JE, Kennergren C, Corey GR. Impact of cardiac implantable electronic device infection: a clinical and economic analysis of the WRAP-IT trial. Circ Arrhythm Electrophysiol. 2020;13:e008280. PubMed PMC

Blomström-Lundqvist C, Traykov V, Erba PA, Burri H, Nielsen JC, Bongiorni MG. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2020;57:E1–E31. PubMed

Sheldon SH, Joyce LD, Friedman PA. Transvenous extraction of right ventricular leads jailed by a bioprosthetic tricuspid valve. J Innov Card Rhythm Manag. 2013;4:1209–12.

Paz Rios LH, Alsaad AA, Guerrero M, Metzl MD. Tricuspid valve-in-valve jailing right ventricular lead is not free of risk. Catheter Cardiovasc Interv. 2020;96:E758–60. PubMed

Chourdakis E, Koniari I, Osman N, Kounis N, Hahalis G, Werner N. Late infective endocarditis after transcatheter mitral valve reconstruction (MitraClip): a case report and a review of the literature. Angiology. 2023;74:205–15. PubMed

Yokoyama H, Ochiai T, Saito S. Infective endocarditis after transcatheter edge-to-edge repair for severe mitral regurgitation; a case report and a systematic review. Catheter Cardiovasc Interv. 2023;102:367–74. PubMed

Gabriels JK, Schaller RD, Koss E, Rutkin BJ, Carrillo RG, Epstein LM. Lead management in patients undergoing percutaneous tricuspid valve replacement or repair: a ‘heart team’ approach. Europace. 2023;25:euad300. PubMed PMC

Deharo JC, Bongiorni M, Rozkovec A, Bracke F, Defaye P, Fernandez-Lozano I et al. Pathways for training and accreditation for transvenous lead extraction: a European Heart Rhythm Association position paper. Europace. 2012;14:124–34. PubMed

Bongiorni MG, Blomström-Lundqvist C, Kennergren C, Dagres N, Pison L, Svendsen JH et al. Current practice in transvenous lead extraction: a European Heart Rhythm Association EP Network survey. Europace. 2012;14:783–6. PubMed

Kusumoto FM, Schoenfeld MH, Wilkoff BL, Berul CI, Birgersdotter-Green UM, Carrillo R. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm. 2017;14:e503–51. PubMed

Bongiorni MG, Burri H, Deharo JC, Starck C, Kennergren C, Saghy L. 2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS. Europace. 2018;20:1217. PubMed

Wilkoff BL, Love CJ, Byrd CL, Bongiorni MG, Carrillo RG, Crossley GH. Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). Heart Rhythm. 2009;6:1085–104. PubMed

Bongiorni MG, Marinskis G, Lip GY, Svendsen JH, Dobreanu D, Blomström-Lundqvist C et al. How European centres diagnose, treat, and prevent CIED infections: results of an European Heart Rhythm Association survey. Europace. 2012;14:1666–9. PubMed

Bongiorni MG, Kennergren C, Butter C, Deharo JC, Kutarski A, Rinaldi CA. The European lead extraction controlled (ELECTRa) study: a European heart rhythm association (EHRA) registry of transvenous lead extraction outcomes. Eur Heart J. 2017;38:2995–3005. PubMed

Bongiorni MG, Soldati E, Zucchelli G, Di Cori, Segreti L, De Lucia. Transvenous removal of pacing and implantable cardiac defibrillating leads using single sheath mechanical dilatation and multiple venous approaches: high success rate and safety in more than 2000 leads. Eur Heart J. 2008;29:2886–93. PubMed PMC

Wazni O, Epstein LM, Carrillo RG, Love C, Adler SW, Riggio DW. Lead extraction in the contemporary setting: the LExICon study: an observational retrospective study of consecutive laser lead extractions. J Am Coll Cardiol. 2010;55:579–86. PubMed

Byrd CL, Wilkoff BL, Love CJ, Sellers TD, Reiser C. Clinical study of the laser sheath for lead extraction: the total experience in the United States. Pacing Clin Electrophysiol. 2002;25:804–8. PubMed

Neuzil P, Taborsky M, Rezek Z, Vopalka R, Sediva L, Niederle P. Pacemaker and ICD lead extraction with electrosurgical dissection sheaths and standard transvenous extraction systems: results of a randomized trial. Europace. 2007;9:98–104. PubMed

Scott PA, Chow W, Ellis E, Morgan JM, Roberts PR. Extraction of pacemaker and implantable cardioverter defibrillator leads: a single-centre study of electrosurgical and laser extraction. Europace. 2009;11:1501–4. PubMed

Mazzone P, Tsiachris D, Marzi A, Ciconte G, Paglino G, Sora N. Advanced techniques for chronic lead extraction: heading from the laser towards the evolution system. Europace. 2013;15:1771–6. PubMed

Bongiorni MG, Segreti L, Di Cori, Zucchelli G, Viani S, Paperini L. Safety and efficacy of internal transjugular approach for transvenous extraction of implantable cardioverter defibrillator leads. Europace. 2014;16:1356–62. PubMed

Koneru JN, Ellenbogen KA. High-risk lead extraction using a hybrid approach: the blade and the lightsaber. J Cardiovasc Electrophysiol. 2014;25:622–3. PubMed

Fischer A, Love B, Hansalia R, Mehta D. Transfemoral snaring and stabilization of pacemaker and defibrillator leads to maintain vascular access during lead extraction. Pacing Clin Electrophysiol. 2009;32:336–9. PubMed

Hamid S, Arujuna A, Ginks M, McPhail M, Patel N, Bucknall C. Pacemaker and defibrillator lead extraction: predictors of mortality during follow-up. Pacing Clin Electrophysiol. 2010;33:209–16. PubMed

Brunner MP, Cronin EM, Wazni O, Baranowski B, Saliba WI, Sabik JF et al. Outcomes of patients requiring emergent surgical or endovascular intervention for catastrophic complications during transvenous lead extraction. Heart Rhythm. 2014;11:419–25. PubMed

Zucchelli G, Di Cori A, Segreti L, Laroche C, Blomstrom-Lundqvist C, Kutarski A et al. Major cardiac and vascular complications after transvenous lead extraction: acute outcome and predictive factors from the ESC-EHRA ELECTRa (European Lead Extraction ConTRolled) registry. Europace. 2019;21:771–80. PubMed

Diemberger I, Mazzotti A, Biffi M, Massaro G, Martignani C, Ziacchi M. From lead management to implanted patient management: systematic review and meta-analysis of the last 15 years of experience in lead extraction. Expert Rev Med Devices. 2013;10:551–73. PubMed

Akhtar Z, Kontogiannis C, Georgiopoulos G, Starck CT, Leung LWM, Lee SY. Comparison of non-laser and laser transvenous lead extraction: a systematic review and meta-analysis. Europace. 2023;25:euad316. PubMed PMC

Rinaldi CA, Diemberger I, Biffi M, Gao YR, Sizto E, Jin N. Safety and success of transvenous lead extraction using excimer laser sheaths: a meta-analysis of over 1700 patients. Europace. 2023;25:euad298. PubMed PMC

Cecchin F, Atallah J, Walsh EP, Triedman JK, Alexander ME, Berul CI. Lead extraction in pediatric and congenital heart disease patients. Circ Arrhythm Electrophysiol. 2010;3:437–44. PubMed

Giannotti Santoro, Segreti L, Zucchelli G, Barletta V, Fiorentini F, Di Cori. Transvenous lead extraction: efficacy and safety of the procedure in octogenarian patients. Pacing Clin Electrophysiol. 2020;43:382–7. PubMed

Diemberger I, Segreti L, Rinaldi CA, Svendsen JH, Kutarski A, Younis A et al. Transvenous lead extraction in patients with cardiac implantable device: the impact of systemic and local infection on clinical outcomes—an ESC-EHRA ELECTRa (European lead extraction controlled) registry substudy. Biology (Basel) 2022;11:615. PubMed PMC

Polewczyk A, Rinaldi CA, Sohal M, Golzio P-G, Claridge S, Cano O. Transvenous lead extraction procedures in women based on ESC-EHRA EORP European Lead Extraction ConTRolled ELECTRa registry: is female sex a predictor of complications? Europace. 2019;21:1890–9. PubMed

Segreti L, Bongiorni MG, Barletta V, Parollo M, Di Cori, Fiorentini F. Transvenous lead extraction: efficacy and safety of the procedure in female patients. Heart Rhythm O2. 2023;4:625–31. PubMed PMC

Di Cori, Auricchio A, Regoli F, Blomström-Lundqvist C, Butter C, Dagres N. Clinical impact of antithrombotic therapy in transvenous lead extraction complications: a sub-analysis from the ESC-EORP EHRA ELECTRa (European Lead Extraction ConTRolled) registry. Europace. 2019;21:1096–105. PubMed

Segreti L, Rinaldi CA, Claridge S, Svendsen JH, Blomstrom-Lundqvist C, Auricchio A. Procedural outcomes associated with transvenous lead extraction in patients with abandoned leads: an ESC-EHRA ELECTRa (European Lead Extraction ConTRolled) registry sub-analysis. Europace. 2019;21:645–54. PubMed

Regoli F, Auricchio A, Di Cori, Segreti L, Blomström-Lunqvist C, Butter C. Impact of anticoagulation therapy on outcomes in patients with cardiac implantable resynchronization devices undergoing transvenous lead extraction: a substudy of the ESC-EHRA EORP ELECTRa (European Lead Extraction ConTRolled) registry. J Cardiovasc Electrophysiol. 2019;30:1086–95. PubMed

Segreti L, Di Cori, Soldati E, Zucchelli G, Viani S, Paperini L. Major predictors of fibrous adherences in transvenous implantable cardioverter-defibrillator lead extraction. Heart Rhythm. 2014;11:2196–201. PubMed

Di Cori, Bongiorni MG, Zucchelli G, Segreti L, Viani S, De Lucia. Large, single-center experience in transvenous coronary sinus lead extraction: procedural outcomes and predictors for mechanical dilatation. Pacing Clin Electrophysiol. 2012;35:215–22. PubMed

Di Cori, Bongiorni MG, Zucchelli G, Lilli A, Coluccia G, Fabiani I. Short-term extraction profile of cardiac pacing leads with hybrid silicone-polyurethane insulator: a pilot study. Int J Cardiol. 2013;168:4432–3. PubMed

Di Cori, Bongiorni MG, Zucchelli G, Segreti L, Viani S, Paperini L. Transvenous extraction performance of expanded polytetrafluoroethylene covered ICD leads in comparison to traditional ICD leads in humans. Pacing Clin Electrophysiol. 2010;33:1376–81. PubMed

Bongiorni MG, Di Cori, Segreti L, Zucchelli G, Viani S, Paperini L. Transvenous extraction profile of Riata leads: procedural outcomes and technical complexity of mechanical removal. Heart Rhythm. 2015;12:580–7. PubMed

Maytin M, Carrillo RG, Baltodano P, Schaerf RH, Bongiorni MG, Di Cori. Multicenter experience with transvenous lead extraction of active fixation coronary sinus leads. Pacing Clin Electrophysiol. 2012;35:641–7. PubMed

Gabriels JK, Kim BS, Shoda M, Birgersdotter-Green U, Di Cori, Zucchelli G. International experience with transvenous lead extractions of an active-fixation coronary sinus pacing lead. Heart Rhythm. 2024;21:686–7. PubMed

Sidhu BS, Gould J, Bunce C, Elliott M, Mehta V, Kennergren C. The effect of centre volume and procedure location on major complications and mortality from transvenous lead extraction: an ESC EHRA EORP European Lead Extraction ConTRolled ELECTRa registry subanalysis. Europace. 2020;22:1718–28. PubMed

Racine H-P, Jacques F, Philippon F. The effect of centre volume and procedure location on major complications and mortality from transvenous lead extraction: an ESC EHRA EORP European Lead Extraction ConTRolled ELECTRa registry subanalysis. Europace. 2021;23:1149. PubMed

Agarwal SK, Kamireddy S, Nemec J, Voigt A, Saba S. Predictors of complications of endovascular chronic lead extractions from pacemakers and defibrillators: a single-operator experience. J Cardiovasc Electrophysiol. 2009;20:171–5. PubMed

Fu HX, Huang XM, Zhong L, Osborn MJ, Asirvatham SJ, Espinosa RE et al. Outcomes and complications of lead removal: can we establish a risk stratification schema for a collaborative and effective approach? Pacing Clin Electrophysiol. 2015;38:1439–47. PubMed

Bongiorni MG, Segreti L, Di Cori, Zucchelli G, Paperini L, Viani S. Overcoming the current issues surrounding device leads: reducing the complications during extraction. Expert Rev Med Devices. 2017;14:469–80. PubMed

Bontempi L, Vassanelli F, Cerini M, D’Aloia A, Vizzardi E, Gargaro A. Predicting the difficulty of a lead extraction procedure: the LED index. J Cardiovasc Med (Hagerstown) 2014;15:668–73. PubMed

Kancharla K, Acker NG, Li Z, Samineni S, Cai C, Espinosa RE. Efficacy and safety of transvenous lead extraction in the device laboratory and operating room guided by a novel risk stratification scheme. JACC Clin Electrophysiol. 2019;5:174–82. PubMed

Jacheć W, Polewczyk A, Polewczyk M, Tomasik A, Kutarski A. Transvenous lead extraction SAFeTY score for risk stratification and proper patient selection for removal procedures using mechanical tools. J Clin Med. 2020;9:361. PubMed PMC

Sidhu BS, Ayis S, Gould J, Elliott MK, Mehta V, Kennergren C et al. Risk stratification of patients undergoing transvenous lead extraction with the ELECTRa Registry Outcome Score (EROS): an ESC EHRA EORP European lead extraction ConTRolled ELECTRa registry analysis. Europace. 2021;23:1462–71. PubMed

Mehta VS, O’Brien H, Elliott MK, Wijesuriya N, Auricchio A, Ayis S. Machine learning-derived major adverse event prediction of patients undergoing transvenous lead extraction: using the ESC EHRA EORP European lead extraction ConTRolled ELECTRa registry. Heart Rhythm. 2022;19:885–93. PubMed

Mehta VS, Ma Y, Wijesuriya N, DeVere F, Howell S, Elliott MK. Enhancing transvenous lead extraction risk prediction: integrating imaging biomarkers into machine learning models. Heart Rhythm. 2024;21:919–28. PubMed

Lin AY, Lupercio F, Ho G, Pollema T, Pretorius V, Birgersdotter-Green U. Safety and efficacy of cardiovascular implantable electronic device extraction in elderly patients: a meta-analysis and systematic review. Heart Rhythm O2. 2020;1:250–8. PubMed PMC

Roeffel S, Bracke F, Meijer A, Van Gelder, Van Dantzig, Botman CJ. Transesophageal echocardiographic evaluation of tricuspid valve regurgitation during pacemaker and implantable cardioverter defibrillator lead extraction. Pacing Clin Electrophysiol. 2002;25:1583–6. PubMed

Franceschi F, Thuny F, Giorgi R, Sanaa I, Peyrouse E, Assouan X. Incidence, risk factors, and outcome of traumatic tricuspid regurgitation after percutaneous ventricular lead removal. J Am Coll Cardiol. 2009;53:2168–74. PubMed

Glover B, Watkins S, Mariani J, Yap S, Asta J, Cusimano R. Prevalence of tricuspid regurgitation and pericardial effusions following pacemaker and defibrillator lead extraction. Int J Cardiol. 2010;145:593–4. PubMed

Coffey JO, Sager SJ, Gangireddy S, Levine A, Viles-Gonzalez JF, Fischer A. The impact of transvenous lead extraction on tricuspid valve function. Pacing Clin Electrophysiol. 2014;37:19–24. PubMed

Givon A, Vedernikova N, Luria D, Vatury O, Kuperstein R, Feinberg MS et al. Tricuspid regurgitation following lead extraction: risk factors and clinical course. Isr Med Assoc J. 2016;18:18–22. PubMed

Rodriguez Y, Mesa J, Arguelles E, Carrillo RG. Tricuspid insufficiency after laser lead extraction. Pacing Clin Electrophysiol. 2013;36:939–44. PubMed

Migliore F, Pittorru R, De Lazzari, Dall’Aglio PB, Cecchetto A, Previtero M. Evaluation of tricuspid valve regurgitation following transvenous rotational mechanical lead extraction. Europace. 2024;26:euae191. PubMed PMC

Candinas R, Duru F, Schneider J, Lüscher TF, Stokes K. Postmortem analysis of encapsulation around long-term ventricular endocardial pacing leads. Mayo Clin Proc. 1999;74:120–5. PubMed

Polewczyk A, Jacheć W, Nowosielecka D, Tomaszewski A, Brzozowski W, Szczęśniak-Stańczyk D. Lead dependent tricuspid valve dysfunction-risk factors, improvement after transvenous lead extraction and long-term prognosis. J Clin Med. 2021;11:89. PubMed PMC

Nazmul MN, Cha YM, Lin G, Asirvatham SJ, Powell BD. Percutaneous pacemaker or implantable cardioverter-defibrillator lead removal in an attempt to improve symptomatic tricuspid regurgitation. Europace. 2013;15:409–13. PubMed

Patel D, Vatterott P, Piccini J, Epstein LM, Hakmi S, Syed I et al. Prospective evaluation of the correlation between gated cardiac computed tomography detected vascular fibrosis and ease of transvenous lead extraction. Circ Arrhythm Electrophysiol. 2022;15:e010779. PubMed PMC

Tułecki L, Polewczyk A, Jacheć W, Nowosielecka D, Tomków K, Stefańczyk P et al. Analysis of risk factors for major complications of 1500 transvenous lead extraction procedures with especial attention to tricuspid valve damage. Int J Environ Res Public Health. 2021;18:9100. PubMed PMC

Svennberg E, Jacobs K, McVeigh E, Pretorius V, Birgersdotter-Green U. Computed tomography-guided risk assessment in percutaneous lead extraction. JACC Clin Electrophysiol. 2019;5:1439–46. PubMed PMC

Saad TF, Hentschel DM, Koplan B, Wasse H, Asif A, Patel DV et al. Cardiovascular implantable electronic device leads in CKD and ESRD patients: review and recommendations for practice. Semin Dial. 2013;26:114–23. PubMed

Schaller RD, Giri J, Epstein AE. Entrapped leads after transcatheter tricuspid valve replacement. JACC Cardiovasc Interv. 2021;14:715–6. PubMed

Noheria A, Van Zyl M, Scott LR, Srivathsan K, Madhavan M, Asirvatham SJ et al. Single-site ventricular pacing via the coronary sinus in patients with tricuspid valve disease. Europace. 2018;20:636–42. PubMed

Arps K, Li B, Allen JC, Jr, Alenezi F, Frazier-Mills C, Al-Khatib SM et al. Association of leadless pacing with ventricular and valvular function. J Cardiovasc Electrophysiol. 2023;34:2233–42. PubMed PMC

Garweg C, Duchenne J, Vandenberk B, Mao Y, Ector J, Haemers P et al. Evolution of ventricular and valve function in patients with right ventricular pacing–A randomized controlled trial comparing leadless and conventional pacing. Pacing Clin Electrophysiol. 2023;46:1455–64. PubMed

Fink T, Eitz T, Sciacca V, Rudolph V, Sohns C, Sommer P et al. Transfemoral leadless pacemaker implantation after interventional or surgical tricuspid valve repair. Europace. 2024;26:euae111. PubMed PMC

Carabelli A, Jabeur M, Jacon P, Rinaldi CA, Leclercq C, Rovaris G et al. European experience with a first totally leadless cardiac resynchronization therapy pacemaker system. Europace. 2021;23:740–7. PubMed PMC

Torres-Quintero L, Molina-Lerma M, Cabrera-Borrego E, García-Orta R, Tercedor-Sánchez L, Álvarez M. His-bundle pacing from the right atrium in a patient with tetralogy of Fallot and a prosthetic tricuspid valve. JACC Clin Electrophysiol. 2020;6:745–6. PubMed

Elliott MK, Vergara P, Wijesuriya N, Mehta VS, Bosco P, Jacon P et al. Feasibility of leadless left ventricular septal pacing with the WiSE-CRT system to target the left bundle branch area: a porcine model and multicenter patient experience. Heart Rhythm. 2022;19:1974–83. PubMed

Knops RE, Lloyd MS, Roberts PR, Wright DJ, Boersma LVA, Doshi R et al. A modular communicative leadless pacing-defibrillator system. N Engl J Med. 2024;391:1402–12. PubMed

Lancellotti P, Pibarot P, Chambers J, La Canna G, Pepi M, Dulgheru R et al. Multi-modality imaging assessment of native valvular regurgitation: an EACVI and ESC council of valvular heart disease position paper. Eur Heart J Cardiovasc Imaging. 2022;23:e171–232. PubMed

Mediratta A, Addetia K, Yamat M, Moss JD, Nayak HM, Burke MC et al. 3D echocardiographic location of implantable device leads and mechanism of associated tricuspid regurgitation. JACC Cardiovasc Imaging. 2014;7:337–47. PubMed

Nucifora G, Badano LP, Allocca G, Gianfagna P, Proclemer A, Cinello M et al. Severe tricuspid regurgitation due to entrapment of the anterior leaflet of the valve by a permanent pacemaker lead: role of real time three-dimensional echocardiography. Echocardiography. 2007;24:649–52. PubMed

Hell MM, Emrich T, Kreidel F, Kreitner KF, Schoepf UJ, Münzel T et al. Computed tomography imaging needs for novel transcatheter tricuspid valve repair and replacement therapies. Eur Heart J Cardiovasc Imaging. 2021;22:601–10. PubMed

Bartkowiak J, Vivekanantham H, Kassar M, Dernektsi C, Agarwal V, Lebehn M, Windecker S, Brugger N, Hahn RT, Praz F. Computed tomography anatomic predictors of outcomes in patients undergoing tricuspid transcatheter edge-to-edge repair. J Cardiovasc Comput Tomogr. 2024;18:259–66. PubMed

Korantzopoulos P, Letsas KP, Grekas G, Goudevenos JA. Pacemaker dependency after implantation of electrophysiological devices. Europace. 2009;11:1151–5. PubMed

Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA et al. 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43:3997–4126. PubMed

Ferrick AM, Raj SR, Deneke T, Kojodjojo P, Lopez-Cabanillas N, Abe H et al. 2023 HRS/EHRA/APHRS/LAHRS expert consensus statement on practical management of the remote device clinic. Europace. 2023;25:euad123. PubMed PMC

Delgado V, Ajmone Marsan N, de Waha S, Bonaros N, Brida M, Burri H et al. 2023 ESC guidelines for the management of endocarditis: developed by the task force on the management of endocarditis of the European Society of Cardiology (ESC) endorsed by the European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of Nuclear Medicine (EANM). Eur Heart J. 2023;44:3948–4042.

Tan EM, DeSimone DC, Sohail MR, Baddour LM, Wilson WR, Steckelberg JM et al. Outcomes in patients with cardiovascular implantable electronic device infection managed with chronic antibiotic suppression. Clin Infect Dis. 2017;64:1516–21. PubMed

Peacock JE, Jr, Stafford JM, Le K, Sohail MR, Baddour LM, Prutkin JM et al. Attempted salvage of infected cardiovascular implantable electronic devices: are there clinical factors that predict success? Pacing Clin Electrophysiol. 2018;41:524–31. PubMed

Topaz M, Chorin E, Schwartz AL, Hochstadt A, Shotan A, Ashkenazi I et al. Regional antibiotic delivery for implanted cardiovascular electronic device infections. J Am Coll Cardiol. 2023;81:119–33. PubMed